Atlas Trials

Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer

Clinical trial NCT06879704 · RECRUITING

Trial details

NCT number
NCT06879704
Sponsor
Centre Henri Becquerel
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2025-05-28
Primary completion
2028-02-28
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.